Submitted:
18 November 2024
Posted:
19 November 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Synthesis of Gadolinium Oxide Nanoparticles
2.2. Physicochemical Methods of Research
2.3. Biomedical Methods of Research
2.3.1. Methods for Evaluating the Effect of Different Concentrations of Aqueous Suspensions of Gd2O3 NPs, on Cytotoxicity/Biocompatibility, Metabolic, Proliferative Activity of Human Fibroblasts and Keratinocytes
2.3.1.1. Cell Lines of Fibroblasts and Keratinocytes and Their Cultivation
2.3.1.2. MTT-Test
2.3.1.3. Determination of Proliferative Activity and Dead/Living Cells Ratio with Trypan Blue Staining
2.3.2. Study of Migration Activity and Rate of Healing of a Model Wound In Vitro on Human Mesenchymal Stromal Cell Culture
2.3.2.1. Culture of Human Adipose–Derived Mesenchymal Stromal Cells
2.3.2.2. Methodology for Assessment of Migration Activity and Rate of In-Vitro Model Wound Healing on Human MSCs
2.4. Statistical Data Processing
3. Results
3.1. Results of Evaluation of Physicochemical Characteristics of Gadolinium Oxide Nanoparticle Powder
3.1.1. Transmission Electron Microscopy
3.1.2. X-Ray Diffraction
3.1.3. Raman Spectroscopy
3.1.4. Scanning Electron Microscopy and Energy Dispersive Analysis of Secondary (Characteristic) X-Rays
3.1.5. Mass Spectrometry
3.2. Result of Evaluation of The Redox Activity of Gd2O3 Nps at Different Concentrations
3.3. Results of Biological Studies on Cell Lines
3.3.1. Results of Studies of the Effect of Different Concentrations of Aqueous Suspensions of Gd2O3 NPs, on Cytotoxicity, Metabolic, Proliferative Activity of Human Fibroblasts
3.3.2. Results of Studies of the Effect of Different Concentrations of Aqueous Suspensions of Gd2O3 NPs, on the Cytotoxicity/Biocompatibility, Metabolic, Proliferative Activity of Human Keratinocytes
3.3.3. Results of the Study of Migration Activity and Healing Rate of a Model Wound In Vitro on Human Mesenchymal Stem Cell Culture
4. Discussion
5. Conclusions
- The method of thermal decomposition of gadolinium carbonate used for the preparation of nanosized gadolinium (III) oxide is suitable for large-scale production and results in obtaining high chemical purity Gd2O3 NPs of cubic structure with an average size of 20-30 nm, and the particles have a relatively high degree of crystallinity.
- In the study of photooxidative degradation of methylene blue dye in the presence of Gd2O3 NPs under red light irradiation, it was found that Gd2O3 nanoparticles showed weakly pronounced antioxidant activity, which depends on the content of particles in the solution. At a concentration of 10-3M, the highest antioxidant activity of Gd2O3 nanoparticles is observed when the rate constant of the dye photodegradation reaction decreases by 5.5% to 9.4x10-3 min-1. When the concentration of Gd2O3 NPs in solution is increased to 10-2M upon irradiation with a red light source, their antioxidant activity changes to pro-oxidant activity, accompanied by a 15% increase in the rate of the methylene blue degradation reaction.
- Studies on cell lines showed a high level of safety and regenerative potential of Gd2O3 NPs, which stimulated fibroblast metabolism at concentrations of 10-2 to 10-3M (27% enhancement) without affecting their proliferation. Gd2O3 NPs stimulated keratinocyte metabolism at concentrations of 10-3M-10-6M, and enhanced keratinocyte proliferation by an average of 35% at concentrations of 10-4M. Gd2O3 NPs accelerated the migration of MSCs, enhancing their proliferation, promoting the healing of the model wound.
Author Contributions
Funding
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Eilers A, Witt S, Walter J. Aptamer-Modified Nanoparticles in Medical Applications. Adv Biochem Eng Biotechnol. 2020;174:161-193. [CrossRef]
- Najahi-Missaoui W, Arnold RD, Cummings BS. Safe Nanoparticles: Are We There Yet? Int J Mol Sci. 2020 Dec 31;22(1):385. [CrossRef]
- Wen J, Moloney EB, Canning A, Donohoe E, Ritter T, Wang J, Xiang D, Wu J, Li Y. Synthesized nanoparticles, biomimetic nanoparticles and extracellular vesicles for treatment of autoimmune disease: Comparison and prospect. Pharmacol Res. 2021 Oct;172:105833. [CrossRef]
- Ali, M. What function of nanoparticles is the primary factor for their hyper-toxicity? Adv Colloid Interface Sci. 2023 Apr;314:102881. [CrossRef]
- Hendricks AR, Guilliams BF, Cohen RS, Tien T, McEwen GA, Borgognoni KM, Ackerson CJ. Cloneable inorganic nanoparticles. Chem Commun (Camb). 2023 Jul 11;59(56):8626-8643. [CrossRef]
- Medical Advisory Secretariat. Nanotechnology: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(19):1-43. [PubMed]
- Dai Y, Wu C, Wang S, Li Q, Zhang M, Li J, Xu K. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent. Nanomedicine. 2018 Feb;14(2):547-555. [CrossRef]
- Wallnöfer EA, Thurner GC, Kremser C, Talasz H, Stollenwerk MM, Helbok A, Klammsteiner N, Albrecht-Schgoer K, Dietrich H, Jaschke W, Debbage P. Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles. Histochem Cell Biol. 2021 Jan;155(1):19-73. [CrossRef]
- Wu L, Lu X, Lu Y, Shi M, Guo S, Feng J, Yang S, Xiong W, Xu Y, Yan C, Shen Z. Kilogram-Scale Synthesis of Extremely Small Gadolinium Oxide Nanoparticles as a T1-Weighted Contrast Agent for Magnetic Resonance Imaging. Small. 2024 Apr;20(14):e2308547. [CrossRef]
- Liu K, Cai Z, Chi X, Kang B, Fu S, Luo X, Lin ZW, Ai H, Gao J, Lin H. Photoinduced Superhydrophilicity of Gd-Doped TiO2 Ellipsoidal Nanoparticles Boosts T1 Contrast Enhancement for Magnetic Resonance Imaging. Nano Lett. 2022 Apr 27;22(8):3219-3227. [CrossRef]
- Riyahi-Alam, N.; Behrouzkia, Z.; Seifalian, A.; HaghgooJahromi, S. Properties Evaluation of a New MRI Contrast Agent Based on Gd-Loaded Nanoparticles. Biol. Trace Elem. Res. 2010, 137, 324–334. [Google Scholar] [CrossRef] [PubMed]
- Сaravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev. 1999;99:2293–3235. [CrossRef]
- Helm, L. Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications. Future Med Chem. 2010;2:385–396. [CrossRef]
- Fleming CL, Wong J, Golzan M, Gunawan C, McGrath KC. Insights from a Bibliometrics-Based Analysis of Publishing and Research Trends on Cerium Oxide from 1990 to 2020. Int J Mol Sci. 2023 Jan 20;24(3):2048. [CrossRef]
- Farias IAP, Dos Santos CCL, Sampaio FC. Antimicrobial Activity of Cerium Oxide Nanoparticles on Opportunistic Microorganisms: A Systematic Review. Biomed Res Int. 2018 Jan 23;2018:1923606. [CrossRef]
- Xue Y, Yang F, Wu L, Xia D, Liu Y. CeO2 Nanoparticles to Promote Wound Healing: A Systematic Review. Adv Healthc Mater. 2024 Mar;13(6):e2302858. [CrossRef]
- Silina E.V., Manturova N.E., Erokhina A.G., Shatokhina E.A., Stupin V.A. Nanomaterials based on cerium oxide nanoparticles for wound regeneration: a literature review. Russian Journal of Transplantology and Artificial Organs. 2024;26(1):113-124. [CrossRef]
- Rajaee A, Wang S, Zhao L, Wang D, Liu Y, Wang J, Ying K. Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging. Phys Med Biol. 2019 Oct 4;64(19):195007. [CrossRef]
- Lux F, Sancey L, Bianchi A, Crémillieux Y, Roux S, Tillement O. Gadolinium-based nanoparticles for theranostic MRI-radiosensitization. Nanomedicine (Lond). 2015;10(11):1801-15. [CrossRef]
- Liu W, Deacon J, Yan H, Sun B, Liu Y, Hegan D, Li Q, Coman D, Parent M, Hyder F, Roberts K, Nath R, Tillement O, Engelman D, Glazer P. Tumor-targeted pH-low insertion peptide delivery of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapy. Transl Oncol. 2020 Nov;13(11):100839. [CrossRef]
- Khorasani A, Shahbazi-Gahrouei D, Safari A. Recent Metal Nanotheranostics for Cancer Diagnosis and Therapy: A Review. Diagnostics (Basel). 2023 Feb 22;13(5):833. [CrossRef]
- Zhang J, Su X, Weng L, Tang K, Miao Y, Teng Z, Wang L. Gadolinium-hybridized mesoporous organosilica nanoparticles with high magnetic resonance imaging performance for targeted drug delivery. J Colloid Interface Sci. 2023 Mar;633:102-112. [CrossRef]
- Ho SL, Choi G, Yue H, Kim HK, Jung KH, Park JA, Kim MH, Lee YJ, Kim JY, Miao X, Ahmad MY, Marasini S, Ghazanfari A, Liu S, Chae KS, Chang Y, Lee GH. In vivo neutron capture therapy of cancer using ultrasmall gadolinium oxide nanoparticles with cancer-targeting ability. RSC Adv. 2020 Jan 3;10(2):865-874. [CrossRef]
- Zhou T, Zhang S, Zhang L, Jiang T, Wang H, Huang L, Wu H, Fan Z, Jing S. Redox ferrocenylseleno compounds modulate longitudinal and transverse relaxation times of FNPs-Gd MRI contrast agents for multimodal imaging and photo-Fenton therapy. Acta Biomater. 2023 Jul 1;164:496-510. [CrossRef]
- Pan J, Zhu X, Chen X, Zhao Y, Liu J. Gd3+-Doped MoSe2 nanosheets used as a theranostic agent for bimodal imaging and highly efficient photothermal cancer therapy. Biomater Sci. 2018 Jan 30;6(2):372-387. [CrossRef]
- Jin S, Zhou L, Gu Z, Tian G, Yan L, Ren W, Yin W, Liu X, Zhang X, Hu Z, Zhao Y. A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells. Nanoscale. 2013 Dec 7;5(23):11910-8. [CrossRef]
- Wang J, Sun X, Xu J, Liu L, Lin P, Luo X, Gao Y, Shi J, Zhang Y. X-ray activated near-infrared persistent luminescence nanoparticles for trimodality in vivo imaging. Biomater Sci. 2024 Jul 23;12(15):3841-3850. [CrossRef]
- Chargari C, Maury P, Texier M, Genestie C, Morice P, Bockel S, Gouy S, Ba M, Achkar S, Lux F, Tillement O, Dufort S, Duc GLE, Debeaumont O, Massard C, Maulard A, Porcel E, Bahleda R, Ammari S, Morel D, Espenel S, Pautier P, Robert C, Deutsch E. Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer. ACS Nano. 2024 Jul 2;18(26):16516-16529. [CrossRef]
- Yu B, Lu X, Feng X, Zhao T, Li J, Lu Y, Ye F, Liu X, Zheng X, Shen Z, Jin X, Chen W, Li Q. Gadolinium Oxide Nanoparticles Reinforce the Fractionated Radiotherapy-Induced Immune Response in Tri-Negative Breast Cancer via cGAS-STING Pathway. Int J Nanomedicine. 2023 Dec 15;18:7713-7728. [CrossRef]
- Hu P, Fu Z, Liu G, Tan H, Xiao J, Shi H, Cheng D. Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma. Front Bioeng Biotechnol. 2019 Nov 27;7:368. [CrossRef]
- Nosrati H, Salehiabar M, Charmi J, Yaray K, Ghaffarlou M, Balcioglu E, Ertas YN. Enhanced In Vivo Radiotherapy of Breast Cancer Using Gadolinium Oxide and Gold Hybrid Nanoparticles. ACS Appl Bio Mater. 2023 Feb 20;6(2):784-792. [CrossRef]
- Korolev DV, Shulmeyster GA, Istomina MS, Evreinova NV, Aleksandrov IV, Krasichkov AS, Postnov VN, Galagudza MM. Fluorescently Labeled Gadolinium Ferrate/Trigadolinium Pentairon(III) Oxide Nanoparticles: Synthesis, Characterization, In Vivo Biodistribution, and Application for Visualization of Myocardial Ischemia-Reperfusion Injury. Materials (Basel). 2022 May 27;15(11):3832. [CrossRef]
- Almas T, Haider R, Malik J, Mehmood A, Alvi A, Naz H, Satti DI, Zaidi SMJ, AlSubai AK, AlNajdi S, Alsufyani R, Ramtohul RK, Almesri A, Alsufyani M, H Al-Bunnia A, Alghamdi HAS, Sattar Y, Alraies MC, Raina S. Nanotechnology in interventional cardiology: A state-of-the-art review. Int J Cardiol Heart Vasc. 2022 Nov 18;43:101149. [CrossRef]
- Lee H, Choi SH, Anzai Y. Glymphatic MRI techniques in sleep and neurodegenerative diseases. Curr Opin Pulm Med. 2022 Nov 1;28(6):499-510. [CrossRef]
- Lilius TO, Mortensen KN, Deville C, Lohela TJ, Stæger FF, Sigurdsson B, Fiordaliso EM, Rosenholm M, Kamphuis C, Beekman FJ, Jensen AI, Nedergaard M. Glymphatic-assisted perivascular brain delivery of intrathecal small gold nanoparticles. J Control Release. 2023 Mar;355:135-148. [CrossRef]
- Lu R, Zhang Y, Tao H, Zhou L, Li H, Chen T, Zhang P, Lu Y, Chen S. Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection. Bioact Mater. 2020 Jun 21;5(4):758-767. [CrossRef]
- Wu S, Xu T, Gao J, Zhang Q, Huang Y, Liu Z, Hao X, Yao Z, Hao X, Wu PY, Wu Y, Yin B, Tang Z. Non-invasive diagnosis of liver fibrosis via MRI using targeted gadolinium-based nanoparticles. Eur J Nucl Med Mol Imaging. 2024 Sep 5. [CrossRef]
- Brune N, Mues B, Buhl EM, Hintzen KW, Jockenhoevel S, Cornelissen CG, Slabu I, Thiebes AL. Dual Labeling of Primary Cells with Fluorescent Gadolinium Oxide Nanoparticles. Nanomaterials (Basel). 2023 Jun 16;13(12):1869. [CrossRef]
- Mehta, KJ. Iron Oxide Nanoparticles in Mesenchymal Stem Cell Detection and Therapy. Stem Cell Rev Rep. 2022 Oct;18(7):2234-2261. [CrossRef]
- Yu T, Zhen M, Li J, Zhou Y, Ma H, Jia W, Wang C. Anti-apoptosis effect of amino acid modified gadofullerene via a mitochondria mediated pathway. Dalton Trans. 2019 Jun 14;48(22):7884-7890. [CrossRef]
- Wang J, Chen C, Li B, Yu H, Zhao Y, Sun J, Li Y, Xing G, Yuan H, Tang J, Chen Z, Meng H, Gao Y, Ye C, Chai Z, Zhu C, Ma B, Fang X, Wan L. Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice. Biochem Pharmacol. 2006 Mar 14;71(6):872-81. [CrossRef]
- Jiao F, Qu Y, Zhou G, Liu Y, Li W, Ge C, Li Y, Hu W, Li B, Gao Y, Chen C. Modulation of oxidative stress by functionalized fullerene materials in the lung tissues of female C57/BL mice with a metastatic Lewis lung carcinoma. J Nanosci Nanotechnol. 2010 Dec;10(12):8632-7. [CrossRef]
- Maksimchuk PO, Hubenko KO, Seminko VV, Karbivskii VL, Tkachenko AS, Onishchenko AI, Prokopyuk VY, Yefimova SL. High antioxidant activity of gadolinium-yttrium orthovanadate nanoparticles in cell-free and biological milieu. Nanotechnology. 2021 Nov 8;33(5). [CrossRef]
- Sushko ES, Vnukova NG, Churilov GN, Kudryasheva NS. Endohedral Gd-Containing Fullerenol: Toxicity, Antioxidant Activity, and Regulation of Reactive Oxygen Species in Cellular and Enzymatic Systems. Int J Mol Sci. 2022 May 5;23(9):5152. [CrossRef]
- Luo S, Ma D, Wei R, Yao W, Pang X, Wang Y, Xu X, Wei X, Guo Y, Jiang X, Yuan Y, Yang R. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis. Acta Biomater. 2022 Jan 15;138:518-527. [CrossRef]
- Kollef MH, Torres A, Shorr AF, Martin-Loeches I, Micek ST. Nosocomial Infection. Crit Care Med. 2021 Feb 1;49(2):169-187. [CrossRef]
- Ji B, Ye W. Prevention and control of hospital-acquired infections with multidrug-resistant organism: A review. Medicine (Baltimore). 2024 Jan 26;103(4):e37018. [CrossRef]
- Flynn CE, Guarner J. Emerging Antimicrobial Resistance. Mod Pathol. 2023 Sep;36(9):100249. [CrossRef] [PubMed]
- Lemiech-Mirowska E, Kiersnowska ZM, Michałkiewicz M, Depta A, Marczak M. Nosocomial infections as one of the most important problems of healthcare system. Ann Agric Environ Med. 2021 Sep 16;28(3):361-366. [CrossRef] [PubMed]
- Aashima, Pandey SK, Singh S, Mehta SK. Biocompatible gadolinium oxide nanoparticles as efficient agent against pathogenic bacteria. J Colloid Interface Sci. 2018 Nov 1;529:496-504. [CrossRef]
- Mohsin MH, Khashan KS, Sulaiman GM, Mohammed HA, Qureshi KA, Aspatwar A. A novel facile synthesis of metal nitride@metal oxide (BN/Gd2O3) nanocomposite and their antibacterial and anticancer activities. Sci Rep. 2023 Dec 20;13(1):22749. [CrossRef]
- Kumar S, Chaudhary S,, Ganga Ram Chaudhary G.R. Effect of fabrication strategies on the in-vitro antimicrobial and antifungal activities of Pr3+ doped Gb2O3 nanoparticles, Environmental Nanotechnology, Monitoring & Management, Volume 16, 2021, 100518, ISSN 2215-1532. [CrossRef]
- Jin J, Zhao Q. Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges. J Nanobiotechnology. 2020 May 14;18(1):75. [CrossRef]
- Ahmad MY, Ahmad MW, Yue H, Ho SL, Cha H, Marasini S, Tegafaw T, Liu S, Ghazanfari A, Chae KS, Chang Y, Lee GH. Chitosan Oligosaccharide Lactate-Coated Ultrasmall Gadolinium Oxide Nanoparticles: Synthesis, In Vitro Cytotoxicity, and Relaxometric Properties. J Nanosci Nanotechnol. 2021 Aug 1;21(8):4145-4150. [CrossRef]
- Liu S, Yue H, Ho SL, Kim S, Park JA, Tegafaw T, Ahmad MY, Kim S, Saidi AKAA, Zhao D, Liu Y, Nam SW, Chae KS, Chang Y, Lee GH. Enhanced Tumor Imaging Using Glucosamine-Conjugated Polyacrylic Acid-Coated Ultrasmall Gadolinium Oxide Nanoparticles in Magnetic Resonance Imaging. Int J Mol Sci. 2022 Feb 4;23(3):1792. [CrossRef]
- Tamanoi F, Yoshikawa K. Inhibition of DNA synthesis and cancer therapies. Enzymes. 2022;52:11-21. [CrossRef]
- Wallnöfer EA, Thurner GC, Kremser C, Talasz H, Stollenwerk MM, Helbok A, Klammsteiner N, Albrecht-Schgoer K, Dietrich H, Jaschke W, Debbage P. Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles. Histochem Cell Biol. 2021 Jan;155(1):19-73. [CrossRef]
- Kraus W., Nolze G.. Powder cell - a program for the representation and manipulation of crystal structures and calculation of the resulting X-ray powder patterns J. Appl. Cryst. 1996. 29. 301-303.
- Artini, C., Costa, G. A., Pani, M., Lausi, A., Plaisier, J. Structural characterization of the CeO2/Gd2O3 mixed system by synchrotron X-ray diffraction. Journal of Solid State Chemistry, 2012. 190, 24–28. [CrossRef]
- Wilson VG. Growth and differentiation of HaCaT keratinocytes. Methods Mol Biol. 2014;1195:33-41. [CrossRef]
- Colombo I, Sangiovanni E, Maggio R, Mattozzi C, Zava S, Corbett Y, Fumagalli M, Carlino C, Corsetto PA, Scaccabarozzi D, Calvieri S, Gismondi A, Taramelli D, Dell'Agli M. HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human Keratinocytes. MediatorsInflamm. 2017;2017:7435621. [CrossRef]
- Suzdaltseva Y, Goryunov K, Silina E, Manturova N, Stupin V, Kiselev SL. Equilibrium among Inflammatory Factors Determines Human MSC-Mediated Immunosuppressive Effect. Cells. 2022 Apr 3;11(7):1210. [CrossRef]
- Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. [CrossRef]
- Pires, A.M.; Davolos, M.R.; Paiva-Santos, C.O.; Stucchi, E.B.; Flor, J. New X-Ray Powder Diffraction Data and Rietveld Refinement for Gd2O3 Monodispersed Fine Spherical Particles. J. Solid State Chem. 2003, 171, 420–423. [Google Scholar] [CrossRef]
- Langford, J.I.; Wilson, A.J.C. Scherrer after Sixty Years: A Survey and Some New Results in the Determination of Crystallite Size. J. Appl. Crystallogr. 1978, 11, 102–113. [Google Scholar] [CrossRef]
- Kislov, A.N.; Zatsepin, A.F. Defect Structure and Vibrational States in Eu-Doped Cubic Gadolinium Oxide. Phys. Chem. Chem. Phys. 2020, 22, 24498–24505. [Google Scholar] [CrossRef] [PubMed]
- Vairapperumal, T.; Pattnaik, S.; Rai, V.K.; Subramanian, B. Structural and Lattice Dynamics Investigation of Double Luminescent Nanosized Hybrid Gd2O3. Mater. Today Commun. 2023, 36, 106500. [Google Scholar] [CrossRef]
- Jegadeesan, P.; Sen, S.; Padmaprabu, C.; Srivastava, S.K.; Das, A.; Amirthapandian, S. Morphological and Optical Investigations on Gd2O3 Nanostructures. Inorg. Chem. Commun. 2023, 150, 110493. [Google Scholar] [CrossRef]
- Le Luyer, C.; García-Murillo, A.; Bernstein, E.; Mugnier, J. Waveguide Raman Spectroscopy of Sol–Gel Gd2O3 Thin Films. J. Raman Spectrosc. 2003, 34, 234–239. [Google Scholar] [CrossRef]
- Dhananjaya, N.; Nagabhushana, H.; Nagabhushana, B.M.; Rudraswamy, B.; Sharma, S.C.; Sunitha, D.V.; Shivakumara, C.; Chakradhar, R.P.S. Effect of Different Fuels on Structural, Thermo and Photoluminescent Properties of Gd2O3 Nanoparticles. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2012, 96, 532–540. [Google Scholar] [CrossRef] [PubMed]
- GarcíaRamírez, V.M.; García Murillo, A.; Carrillo Romo, F.d.J.; Alvarez González, R.I.; Madrigal Bujaidar, E. A New Ultrafine Luminescent La2O3:Eu3+ Aerogel. Gels 2023, 9, 615. [Google Scholar] [CrossRef] [PubMed]
- Wakefield, G.; Holland, E.; Dobson, P.J.; Hutchison, J.L. Luminescence Properties of Nanocrystalline Y2O3:Eu. Adv. Mater. 2001, 13, 1557. [Google Scholar] [CrossRef]
- Guo, H.; Dong, N.; Yin, M.; Zhang, W.; Lou, L.; Xia, S. Visible Upconversion in Rare Earth Ion-Doped Gd2O3 Nanocrystals. J. Phys. Chem. B 2004, 108, 19205–19209. [Google Scholar] [CrossRef]
- Maalej, N.M.; Qurashi, A.; Assadi, A.A.; Maalej, R.; Shaikh, M.N.; Ilyas, M.; Gondal, M.A. Synthesis of Gd2O3:EuNanoplatelets for MRI and Fluorescence Imaging. Nanoscale Res. Lett. 2015, 10, 215. [Google Scholar] [CrossRef] [PubMed]
- Kostova, I.; Traykova, M.; Rastogi, V. New Lanthanide Complexes with Antioxidant Activity. Med. Chem. (Los. Angeles). 2008, 4, 371–378. [Google Scholar] [CrossRef] [PubMed]
- Pugachevskii, M.A.; Rasseko, D.S.; Stupin, V.A.; Manturova, N.E.; Artyushkova, E.B.; Silina, E.V. Effect of CeO2 Nanoparticles on Hydroxyl Radicals in EPR Studies of the Photodegradation of Methylene Blue under Influence of Red Light. J. Mol. Liq. 2024, 404, 124946. [Google Scholar] [CrossRef]
- Islam M.T., Tsnobiladze V. The Application, Safety, and Recent Developments of Commonly Used Gadolinium-Based Contrast Agents in MRI: A Scoping Review. EMJ. 2024;9[3]:63-73. [CrossRef]
- Coimbra S., Rocha S., Sousa N.R., Catarino C., Belo L., Bronze-da-Rocha E., Valente M.J., Santos-Silva A. Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents—A Review. Int. J. Mol. Sci. 2024, 25(7), 4071. [CrossRef]
- Arino T, Faulkner D, Bustillo KC, An DD, Jorgens D, Hébert S, McKinley C, Proctor M, Loguinov A, Vulpe C, Abergel RJ. Electron microscopy evidence of gadolinium toxicity being mediated through cytoplasmic membrane dysregulation. Metallomics. 2024 Oct 4;16(10):mfae042. [CrossRef]
- Wang, W., Song, S., Liu, W. et al. Two-photon excited luminescence of structural light enhancement in subwavelength SiO2 coating europium ion-doped paramagnetic gadolinium oxide nanoparticle and application for magnetic resonance imaging. Discover Nano18, 85 (2023). [CrossRef]
- Whba F., Mohamed F., Idris M. Evaluation of physicochemical and biocompatibility characteristics of gadolinium oxide nanoparticles as magnetic resonance imaging contrast agents. Radiation Physics and Chemistry, 2023;2013: 111189. [CrossRef]
- Verma V.K, Srivastava P., Sabbarwal S, Singh M., Koch B., Kumar M. White Light Emitting Gadolinium Oxide Nanoclusters for In-vitro Bio-imaging, ChemistrySelect. 2022; 47(7): e202202335. [CrossRef]
- Zheng C, Tian X, Cai J, Huang L, Wang S, Yang F, Ma Y, Xie F, Li L. In vivo immunotoxicity of Gd2 O3 :Eu3+ nanoparticles and the associated molecular mechanism. J Biochem Mol Toxicol. 2020 Nov;34(11):e22562. [CrossRef]
- Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019 Dec 2;4:22. [CrossRef]
- Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, Hua D, Shao C, Shi Y. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther. 2022 Mar 21;7(1):92. [CrossRef]
- Hemmer, E.; Yamano, T.; Kishimoto, H.; Venkatachalam, N.; Hyodo, H.; Soga, K. Cytotoxic Aspects of Gadolinium Oxide Nanostructures for Up-Conversion and NIR Bioimaging. ActaBiomater 2013, 9, 4734–4743. [Google Scholar] [CrossRef] [PubMed]
- Dhanalakshmi, S.; Senthil Kumar, P.; Karuthapandian, S.; Muthuraj, V.; Prithivikumaran, N. Design of Gd2O3 Nanorods: A Challenging Photocatalyst for the Degradation of Neurotoxicity Chloramphenicol Drug. J. Mater. Sci. Mater. Electron. 2019, 30, 3744–3752. [Google Scholar] [CrossRef]












| Element | Gd2O3 | Element | Gd2O3 |
| Na | < 0.5 | La | 6 |
| Mg | 1 | Се | <0.1 |
| Al | 5 | Pr | 0.6 |
| Si | <10 | Nd | <0.1 |
| K | 0.6 | Sm | 1 |
| Ca | 0.8 | Eu | 5 |
| Ti | <0.01 | Tb | 3 |
| V | <0.01 | Dy | < 0.1 |
| Cr | <0.01 | Ho | 20 |
| Mn | 1 | Er | < 0.1 |
| Fe | 1 | Tm | 2 |
| Co | <0.02 | Yb | < 0.1 |
| Ni | <0.02 | Pb | < 0.2 |
| Cu | 1 | Bi | < 0.2 |
| Zn | 2 | Th | < 0.2 |
| Y | 0.6 | U | < 0.1 |
| Mean | Std. Deviation | Std. Error | 95% Confidence Interval for Mean | Minimum | Maximum | ||
| Lower | Upper | ||||||
| МТТ, optical density value (OD) | |||||||
| Control_0 | 0.432 | 0.011 | 0.005 | 0.425 | 0.438 | 0.423 | 0.453 |
| Control (H2O) | 0.441 | 0.014 | 0.006 | 0.433 | 0.448 | 0.420 | 0.462 |
| Control (average) | 0.437 | 0.013 | 0.004 | 0.428 | 0.445 | 0.420 | 0.462 |
| Gd2O3 (10-2M) | 0.560 | 0.017 | 0.005 | 0.548 | 0.570 | 0.524 | 0.588 |
| Gd2O3 (10-3M) | 0.556 | 0.012 | 0.003 | 0.548 | 0.563 | 0.540 | 0.575 |
| Gd2O3 (10-4M) | 0.479 | 0.009 | 0.003 | 0.473 | 0.485 | 0.468 | 0.493 |
| Gd2O3 (10-5M) | 0.467 | 0.017 | 0.005 | 0.456 | 0.478 | 0.435 | 0.501 |
| Total | 0.499 | 0.051 | 0.006 | 0.486 | 0.512 | 0.420 | 0.588 |
| Number of fibroblasts, x100,000 cells | |||||||
| Control (average) | 4.40 | 0.453 | 0.171 | 3.98 | 4.82 | 3.69 | 4.99 |
| Gd2O3 (10-2M) | 4.59 | 0.968 | 0.366 | 3.69 | 5.48 | 3.40 | 6.16 |
| Gd2O3 (10-3M) | 4.71 | 0.452 | 0.171 | 4.29 | 5.12 | 4.05 | 5.34 |
| Gd2O3 (10-4M) | 4.02 | 0.287 | 0.108 | 3.75 | 4.29 | 3.76 | 4.52 |
| Gd2O3 (10-5M) | 4.10 | 0.930 | 0.352 | 3.24 | 4.96 | 2.40 | 5.10 |
| Total | 4.36 | 0.691 | 0.117 | 4.13 | 4.60 | 2.40 | 6.16 |
| Mean | Std. Deviation | Std. Error | 95% Confidence Interval for Mean | Minimum | Maximum | ||
| Lower | Upper | ||||||
| МТТ, optical density value (OD) | |||||||
| Control | 0.322 | 0.007 | 0.002 | 0.316 | 0.329 | 0.315 | 0.334 |
| Gd2O3 (10-3M) | 0.335 | 0.011 | 0.004 | 0.324 | 0.345 | 0.322 | 0.351 |
| Gd2O3 (10-4M) | 0.339 | 0.010 | 0.003 | 0.329 | 0.348 | 0.321 | 0.353 |
| Gd2O3 (10-5M) | 0.341 | 0.007 | 0.003 | 0.334 | 0.348 | 0.333 | 0.355 |
| Total | 0.334 | 0.011 | 0.002 | 0.330 | 0.339 | 0.315 | 0.355 |
| Number of keratinocytes, x100,000 cells | |||||||
| Control | 1.47 | 0.268 | 0.101 | 1.21 | 1.71 | 1.11 | 1.88 |
| Gd2O3 (10-3M) | 1.33 | 0.157 | 0.059 | 1.18 | 1.47 | 1.17 | 1.64 |
| Gd2O3 (10-4M) | 2.02 | 0.515 | 0.194 | 1.53 | 2.49 | 1.47 | 2.87 |
| Gd2O3 (10-5M) | 1.71 | 0.192 | 0.072 | 1.53 | 1.89 | 1.41 | 1.99 |
| Total | 1.63 | 0.399 | 0.075 | 1.47 | 1.78 | 1.11 | 2.87 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).